Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Boston Scientific/Cardiovascular Imaging Systems

This article was originally published in The Gray Sheet

Executive Summary

Firms announce that the closing of their previously announced $100 mil. merger will be delayed "until at least Jan. 12, 1995" in accordance with their agreement to allow the Federal Trade Commission more time to investigate the deal. The merger, announced Aug. 31, would give minimally invasive surgery products manufacturer Boston Scientific access to Sunnyvale, California-based CVIS' intravascular ultrasound technology ("The Gray Sheet" Sept. 5, p. 1 ). CVIS says the delay "has not significantly altered the course of the transaction"

Latest Headlines
See All
UsernamePublicRestriction

Register

MT003206

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel